Shi J - Search Results

1

Inhibition of Tumor Metastasis by Liquid-Nitrogen-Shocked Tumor Cells with Oncolytic Viruses Infection.

Wu Q, Huang H, Sun M, Zhang R, Wang J, Zheng H, Zhu C, Yang S, Shen X, Shi J, Liu F, Wu W, Sun J, Liu F, Li H, Gu Z. Wu Q, et al. Among authors: shi j. Adv Mater. 2023 Jul;35(28):e2212210. doi: 10.1002/adma.202212210. Epub 2023 May 24. Adv Mater. 2023. PMID: 37002917

2

Tailoring the physicochemical properties of nanomaterials for immunomodulation.

Deng J, Wang J, Shi J, Li H, Lu M, Fan Z, Gu Z, Cheng H. Deng J, et al. Among authors: shi j. Adv Drug Deliv Rev. 2022 Jan;180:114039. doi: 10.1016/j.addr.2021.114039. Epub 2021 Nov 3. Adv Drug Deliv Rev. 2022. PMID: 34742825 Review.

3

Cell delivery devices for cancer immunotherapy.

Wen P, Wu W, Wang F, Zheng H, Liao Z, Shi J, Zhu C, Zhao P, Cheng H, Li H, Gu Z. Wen P, et al. Among authors: shi j. J Control Release. 2023 Jan;353:875-888. doi: 10.1016/j.jconrel.2022.11.041. Epub 2022 Dec 19. J Control Release. 2023. PMID: 36442617 Review.

4

Unmanned Aerial Vehicle Mediated Drug Delivery for First Aid.

Sheng T, Jin R, Yang C, Qiu K, Wang M, Shi J, Zhang J, Gao Y, Wu Q, Zhou X, Wang H, Zhang J, Fang Q, Pan N, Xue Y, Wang Y, Xiong R, Gao F, Zhang Y, Lu H, Yu J, Gu Z. Sheng T, et al. Among authors: shi j. Adv Mater. 2023 Mar;35(10):e2208648. doi: 10.1002/adma.202208648. Epub 2023 Jan 29. Adv Mater. 2023. PMID: 36563167

5

Engineered bacteria for augmented in situ tumor vaccination.

Shen X, Zhu C, Liu X, Zheng H, Wu Q, Xie J, Huang H, Liao Z, Shi J, Nan K, Wang J, Mao X, Gu Z, Li H. Shen X, et al. Among authors: shi j. Biomater Sci. 2023 Feb 14;11(4):1137-1152. doi: 10.1039/d2bm01593e. Biomater Sci. 2023. PMID: 36601796 Review.

6

Local Drug Delivery Techniques for Triggering Immunogenic Cell Death.

Ren E, Wang Y, Liang T, Zheng H, Shi J, Cheng Z, Li H, Gu Z. Ren E, et al. Among authors: shi j. Small Methods. 2023 Sep;7(9):e2300347. doi: 10.1002/smtd.202300347. Epub 2023 May 31. Small Methods. 2023. PMID: 37259275 Review.

7

Rationally designed approaches to augment CAR-T therapy for solid tumor treatment.

Zhu C, Wu Q, Sheng T, Shi J, Shen X, Yu J, Du Y, Sun J, Liang T, He K, Ding Y, Li H, Gu Z, Wang W. Zhu C, et al. Among authors: shi j. Bioact Mater. 2023 Nov 26;33:377-395. doi: 10.1016/j.bioactmat.2023.11.002. eCollection 2024 Mar. Bioact Mater. 2023. PMID: 38059121 Free PMC article.

8

Lymph node-biomimetic scaffold boosts CAR-T therapy against solid tumor.

Liao Z, Jiang J, Wu W, Shi J, Wang Y, Yao Y, Sheng T, Liu F, Liu W, Zhao P, Lv F, Sun J, Li H, Gu Z. Liao Z, et al. Among authors: shi j. Natl Sci Rev. 2024 Jan 11;11(4):nwae018. doi: 10.1093/nsr/nwae018. eCollection 2024 Apr. Natl Sci Rev. 2024. PMID: 38440217 Free PMC article.

9

Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells.

Shi J, Wu W, Chen D, Liao Z, Sheng T, Wang Y, Yao Y, Wu Q, Liu F, Zhou R, Zhu C, Shen X, Mao Z, Ding Y, Wang W, Dotti G, Sun J, Liang X, Fang W, Zhao P, Li H, Gu Z. Shi J, et al. Nat Mater. 2024 Mar 6. doi: 10.1038/s41563-024-01825-z. Online ahead of print. Nat Mater. 2024. PMID: 38448658

10

Cryo-shocked tumor cells deliver CRISPR-Cas9 for lung cancer regression by synthetic lethality.

Liu F, Xin M, Feng H, Zhang W, Liao Z, Sheng T, Wen P, Wu Q, Liang T, Shi J, Zhou R, He K, Gu Z, Li H. Liu F, et al. Among authors: shi j. Sci Adv. 2024 Mar 29;10(13):eadk8264. doi: 10.1126/sciadv.adk8264. Epub 2024 Mar 29. Sci Adv. 2024. PMID: 38552011 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23,472 results

Search Page